ptv healthcare capital meet early meet often ptv senior regulatory advisor tony blank on the consumerization of the fda watch ptv’s featured session at sxsw dr clay johnston of dell med school and the ceos of jj and ibm discuss collaborative innovation in the digital health age ptv’s lauren chauret named austin under  award winner awards recognize emerging leaders who excel in their professions and are dedicated to serving the austin community a look back at our successes and achievements from   year in review the power of persistence apollo endosurgery founder and chief commercial officer dennis mcwilliams offers inspiring words for startup entrepreneurs this is the best time to be a healthcare investor in the past two decades rick anderson managing director ptv healthcare capital top talkssxsw awardsyear in reviewadvice from the topopportunity we enable healthcare innovation ptv healthcare capital is an austin texas based latestage venture and expansion capital firm committed to enabling healthcare innovation we are a highly collaborative team acting with integrity and adding value in all that we do we provide access to capital expertise and critical business expansion resources we believe we make a difference through our role as investors partners and leaders in bringing disruptive medical technologies to markets worldwide news spotlight jul  apollo endosurgery inc announces closing of public offering and underwriters’ full exercise of overallotment option more » jul  apollo endosurgery inc announces pricing of  million public offering more » jun  new podcast ptv senior regulatory advisor tony blank on the consumerization of the fda more » apollo endosurgery  ptv healthcare capital apollo endosurgery defining the future of endoscopic surgery headquartered in austin texas apollo endosurgery inc is a medical device company focused on less invasive therapies for the treatment of obesity a condition facing over  million people globally as well as other gastrointestinal disorders its device based therapies are an alternative to invasive surgical procedures thus lowering complication rates and reducing total healthcare costs apollo’s products are offered in over  countries today  wwwapolloendocom apen stock activity in the newsapollo endosurgery completes merger with lpath initiates trading on nasdaq as ‘apen’ apollo endosurgery announces successful completion of lapband® fda postapproval study apollo endosurgery and zillion announce the launch of orbera® coach   team members  ptv healthcare capital leadership ptv team advisors rick anderson leadership rick anderson managing director rick has over  years of senior executive leadership experience in the medical device industry prior to joining ptv rick was company group chairman johnson  johnson and worldwide franchise chairman cordis corporation rick also served as president of cordis corporation and was previously worldwide franchise vice president of centocor inc which merged with johnson  johnson in  rick was a key architect behind the launch of the world’s first drugeluting stent the cypher® sirolimuseluting coronary stent this breakthrough innovation for the treatment of restenosis reblockage has been used to treat more than three million patients worldwide before joining johnson  johnson rick served at racal healthcare inc where he was vice president global marketing and prior to that he spent a decade with boehringer mannheim pharmaceuticals and allergan pharmaceuticals in various us and global sales sales management and marketing management roles rick holds a bba in marketing from mississippi state university he served five years in the us army where he obtained the rank of captain rick serves as a texas health catalyst advisory panel member for the university of texas dell medical school and as a strategic advisory group member for nikon corporation rick is also a member of the economic advisory board of mississippi state university a consultant member of the society for cardiovascular angiography and interventions and he has worked within the industry to shape global education of interventional specialties he participates in the advamed venture capital advisory council and the dartmouth device development d symposium executive committee and he is a director for the heart rhythm society hrs consulting services and a member of the accelerated innovation program working group for the national heart lung and blood institute nhlbi rick currently sits on the board of ptv portfolio company apollo endosurgery and he serves as chairman of the board for cardiva medical he also serves as an independent director on convatec plc a ftsi  company he previously served as a director for intersect ent before the company went public in july  a director at corventis prior to its acquisition by medtronic in june  a director at cameron health prior to its acquisition by boston scientific in june  and chairman of the board for idev technologies prior to its acquisition by abbott in august  he also previously served as a director of insite vision and chairman of the board for tryton medical contact httpwwwlinkedincompubrickandersonaaa connect with rick on linkedin we believe that great returns are driven by disciplined leadership we challenge our management teams and ourselves every day to build sustainable growing companies that make a difference for patients around the world ptv team member since  boards matt crawford leadership matt crawford founding managing director matt founded ptv healthcare capital a venture capital firm in  and has served since then as managing director matt has spent his  year career in the private equity venture capital banking and finance industries he has served on more than  healthcare company boards of directors and currently serves on the boards of directors of several private companies matt is an executive committee member for the university of texas chancellor’s council as well as an active member of the external advisory committee of the university of texas department of biomedical engineering most recently matt was appointed to the wake forest college campaign committee and the deacon club board of directors matt holds a ba in history and an mba from wake forest university representative investments that matt managed andor sourced apollo endosurgery private asuragen private cameron health sold to boston scientific cardiva medical private idev sold to abbott intuity medical private ldr spine ipo october  ldrh onx life technologies sold to cryolife osteobiologics sold to smith  nephew contact httpswwwlinkedincompubmattcrawfordba connect with matt on linkedin healthcare represents more than  of us gdp and provides extraordinary opportunities to improve the lives of millions of people and to create long term sustainable investment results ptv team member since  boards lauren chauret leadership lauren chauret director of operations lauren serves on the investment committee and works with the investment team on sourcing evaluating and structuring new investments she is responsible for directing investor relations finance accounting and compliance functions in addition to general fund administration and oversight of daytoday operations prior to her role as partner and director of operations lauren served as finance manager at ptv lauren also serves as an observer on the board of directors for cardiva medical lauren graduated with high honors from the mccombs school of business at the university of texas at austin and holds a bba in finance lauren currently serves as a member on the board of directors for the ann richard school foundation an organization focused on advancing education and empowering young women leaders lauren is a member of the private equity women investor network and the dell medical school society for health  business she also is an active member of the junior league of austin where she has served as project chair and volunteered with community organizations including the settlement home run club and mobile loaves and fishes in  lauren was recognized as an austin under  awards winner in the healthcare and life sciences category a distinction that recognizes leadership in one’s respective industry as well as a strong commitment to serving the austin community in  lauren was selected as a finalist as an austin under  awards also in the healthcare and life sciences category a distinction that recognizes leadership in one’s respective industry as well as a strong commitment to serving the austin community in  lauren was recognized by the austin business journal as a profiles in power rising star finalist a distinction that celebrates women under  for their achievements in business and contributions to the community thus far for current or prospective investor inquiries please contact lauren contact laurenptvhccom email lauren httpwwwlinkedincompublaurenchauretb connect with lauren on linkedin lauren loves running and completed her second chicago marathon in  with team bright pink to raise awareness of lifesaving programs for young women ptv team member since  clay samford ptv team clay samford senior associate clay joined ptv in march of   as senior associate clay engages in all aspects of venture capital investing including business plan evaluation due diligence internal research term sheet negotiation and deal execution  clay is also responsible for supporting existing portfolio companies as well as completing quarterly valuation and investment reporting clay previously worked within the assurance practice at ernst  young in austin texas where he worked on multiple initial public offerings of client companies clay graduated from the mccombs school of business at the university of texas at austin with a masters in professional accounting degree and a minor in finance clay is a certified public accountant in the state of texas for questions on business plan submission please contact clay contact clayptvhccom email clay wwwlinkedincompubclaytonsamford connect with clay on linkedin clay has travelled to over  countries within europe africa north and south america ptv team member since  alexa bourdage ptv team alexa bourdage marketing associate as marketing associate alexa designs and executes ptv’s marketing and communications strategies including maintaining and expanding the firm’s web and social media presence and overseeing the firm’s public relations she develops new initiatives for ptv’s brand recognition and reputation and supports the team with collateral development event planning and other special projects for media and press inquiries please contact alexa contact alexaptvhccom email alexa wwwlinkedincominalexabourdage connect with alexa on linkedin alexa was the feature twirler at the university of texas  she’s been twirling since she was  ptv team member since  lisa rainone ptv team lisa rainone executive assistant lisa is the newest member to the ptv team  lisa has a bba from the university of san diego and has extensive experience in procurement and energyfacility management  lisa works with ptv’s bookkeeping office management as well as the coordination of day to day activities  lisa also administrates ptv’s contact and data management systems for questions regarding ptv’s annual meeting or technical support when accessing ptv’s online investor reporting system please contact lisa hunter lentz advisors hunter lentz ptv professional hunter formally worked for ptv as a senior analyst he now works for ptv portfolio company cardvia medical where he develops companywide strategy for sales finance and business development initiatives   contact httpwwwlinkedincompubhunterlentzb connect with hunter on linkedin hunter plays australian rules football aka “footy” he’s only broken  bones so far ptv team member since  dave cox advisors dave cox entrepreneur in residence david j “dave” cox vice president us sales endoarterial peripheral vascular was responsible until april of  for leading the us endoarterial sales organization as well as sales operations and sales training dave oversaw the development and execution of the strategy for the endoarterial business which included a robust portfolio of devices for the treatment of deep vein thrombosis and peripheral arterial disease the sales force was comprised of four area directors twenty three district managers one hundred sixty five sales representatives and eighty six clinical specialist generating m in annual sales in cy revenues grew  in a us market growing  the growth was fueled by the launch of inpact admiral the second drug coated angioplasty balloon for the treatment of pad stocked in the first year in just over  hospitals that generated sales of over m in parallel dave took direct distribution expense down from  of revenues to  over the course of  years through increasing revenues and opportunistic sales force remodeling dave joined medtronic through the acquisition of covidien  that had previously acquired ev  and was with the company for  years most recently dave also served as leader of the us endovenous sales team in addition to his responsibilities in leading the commercial efforts of the us endoarterial franchise the endovenous sales team consisted of  field persons and generated m in revenue prior to this he served as south zone vice president of sales for both the endoarterial and endovenous us businesses and earned backtoback president’s club recognition in  and  he has held several leadership roles within the organizations throughout his tenure including regional sales manager area sales director and senior director of corporate accounts dave has a solid track record of building high performance teams strategic decision making and driving a high level of accountability to deliver on objectives dave has garnered more than  years of experience in sales and sales management of highly technical products prior to medtronic dave served in positions of increasing responsibility within the medical device and pharmaceutical industries including roles at centocor inc boehringer mannheim co and allergan pharmaceuticals since leaving medtronic in april  dave has recently completed a year of full time consulting role to nebupure healthcare a watertech holdings company both very early stage precommercial companies both are focused on further development of a proprietary air disinfecting system for healthcare spaces as well as other spaces where hais and cai’s are a threat dave was involved in platform form factor build out testing to include epa registration and developing the commercial “go to market” strategy dave has also just been named a board advisory and mentor for the charleston device initiative cmdi a joint venture between the medical university of south carolina and medtech catalyst to assist in evaluating new technologies for funding and early stage commercial strategy mentoring post funding dave holds two bachelor’s degrees in business administration in marketing and production management as well as a minor in economics from james madison university contact httpswwwlinkedincomindavecoxba connect with dave on linkedin john heller advisors john heller entrepreneur in residence john heller is an executive leader with expertise in operations finance and supply chain management across a variety of consumer package goods and technology based industries he is currently the cfo of swell brands and previously served as the chief operating office for yummy earth the leading organic candy company within the natural food channel where he had responsibility for all operations including the management of outsourced manufacturing operations in mexico france and the united states prior to this role john was the vice president of supply chain services for keurig green mountain where he was responsible for developing effective supply chain relationships across the mass merchant specialty retail club and grocery channels  through his leadership the scs team established productive partnerships with customers that allowed for fulfillment and distribution operations focused on speed efficiency and effectiveness  he also served as the vice president of logistics where he was responsible for the integration and management of the logistics and fulfillment operations of multiple business units into one enterprise organization with almost  billion of annual revenue  in his initial role at keurig john was the vice president of finance and operations leading his teams during a period of revenue growth from  million to  billion  he also managed all distribution and fulfillment activities as well as the production planning of all overseas contract manufacturing prior to keurig john served in a variety of finance and operations leadership roles in the high tech industry and as an ma advisor with pricewaterhousecoopers where he earned his cpa designation  john started his leadership career as an officer in the united states army serving in a number of roles including blackhawk helicopter pilot and associate professor at usma  john earned a bs from the united states military academy an mba from duke university and he is currently completing his masters in supply chain management from penn state university contact httpswwwlinkedincominjohnhellerba connect with john on linkedin rod williams advisors rod williams entrepreneur in residence rod williams recently was the president and ceo of heart rhythm society consulting hrscs based in los angeles ca rod holds a bachelor of science degree in marketing from university of southern california usc as well as a master of business administration in finance investment banking from usc he also attended the wharton school of business general management executive leadership program while at usc rod participated on a football scholarship and gained ncaa academic allamerican honors along with numerous academic awards as the top studentathlete at the university rod was drafted into the national football league in  in his previous role at hrs consulting services the hrs board of trustees recruited rod to establish specific lines of business services to improve the operating performance and profitability of hospitals idn’s and cardiology practices prior to assuming this key post within heart rhythm society rod previously served in senior executive positions with st jude medical ge healthcare johnson and johnson and bausch  lomb in executive commercial and strategic roles although most of his commercial experience has been in the interventional cardiology sector rod has demonstrated incredible agility and range across a broad section of specialty segments in cardiovascular imaging and ophthalmology with large and small cap companies rod has proven success in building out commercial organizations and leading companies through a growth cycle while strengthening the company’s product portfolio through licensing and acquisitions and strengthening their commercial planning competencies this has led to significant leverage for companies while expanding their revenue growth his leadership and competitiveness resulting in success has been recognized at every level from academics professional athletics and his business career dennis mcwilliams advisors dennis mcwilliams entrepreneur in residence dennis is currently the president and chief commercial officer of apollo endosurgery inc a company he founded with ptv apollo develops medical devices for natural orifice surgical procedures prior to ptv and apollo dennis was a cofounder and chief operating officer at chrysalis biotechnology which developed synthetic proteins for bone and dermal repair chrysalis was acquired in  by orthologic corporation at which point dennis joined ptv as entrepreneur in residence dennis also worked at george kozmetzky’s ic institute austin texas a technology “think tank” developing technology commercialization strategies for a variety of public and private entities including university of texas medical branch nasa and cia labs dennis received a bs with honors from the university of texas at austin and a ms in engineering management from stanford university dennis was recently named an outstanding young texas ex an honor given annually to four graduates of the university of texas contact wwwlinkedincompubdennismcwilliamsa connect with dennis on linkedin httpstwittercomdenmac follow dennis on twitter kim bridges advisors kim bridges business advisor kim brings nearly  years of medical device experience in cardiology radiology vascular surgery neurology and women’s health kim currently serves as the president and ceo of halt medical a privately held company developing minimally invasive uterine sparing solutions for women who suffer from symptomatic fibroids prior to halt she served at spectranetics nyse spnc as senior vice president of the vascular intervention business unit which more than doubled us revenue under her leadership  prior to joining spectranetics kim has held several global vice president and management roles in sales marketing therapy development and general business management at companies such as blockade medical stryker neurovascular concentric medical johnson  johnson and guidant corporation she received her executive mba at the university of southern california marshall school of business and bs in management from pepperdine university contact httpswwwlinkedincominkimbridges connect with kim on linkedin karen a licitra advisors karen a licitra business advisor karen licitra retired from johnson  johnson new brunswick  new jersey in august   during her  year career in health care at johnson  johnson karen has been known for creating innovative growth platforms and has had a wealth of domestic and global industry experience in sales marketing commercial and general management from january  thru august  karen held the position of corporate vice president worldwide government affairs  policy in this role she was responsible for johnson  johnson’s engagements with government leaders around the world at the multilateral national and state levels her organization also leads development of johnson  johnson public policy prior to her current role karen was worldwide chairman global medical solutions group within johnson  johnson’s medical device and diagnostics segment in that role she was responsible for setting the strategy and vision for an bn global portfolio of healthcare companies including visioncare diabetes care ortho clinical diagnostics and advanced sterilization products as well as the sedation business unit she also led the medical device diagnostics center of excellence for regularory affairs before her rise to worldwide chairman karen was company group chairman for johnson  johnson and worldwide franchise chairman for ethicon endosurgery inc and johnson  johnson medical canada ms licitra holds a bs in commerce from rider college she is a member of the board of directors for sibone inc and a member of the board of trustees for the saint peter’s healthcare system ms licitra also serves as chair emeritus for the campaign to end obesity which advances us national policy and platforms to combat obesity as well as chair of the campaign’s advisory council richard s dakers advisors richard s dakers business advisor richard brings over  years of international business experience spanning sales sales management marketing strategy development licensing acquisitions divestitures minority equity investing as well as nonexecutive board member experience a proven leader with a track record of talent development he began his career with johnson and johnson in  in scotland with the ethicon suture division and spent the first  years of his career in europe the us and middle east in increasing positions of responsibility in sales marketing and franchise management in august  richard moved to cincinnati ohio as part of the global ethicon endosurgery franchise startup team as a director of marketing and from  until  held positions of increasing responsibility in business development and strategic planning and strategic marketing for the global ethicon endosurgery franchise richard was a member of the ees global management board in september  richard was named as vp of business development and strategic planning for the medical device and diagnostics group of johnson  johnson and led multiple public and private acquisitions and was a member of the investment committee of jjdc the oldest and most successful corporate investment group in the industry in july of  richard joined the cordis franchise global management board as vp of franchise development with responsibility for business development and strategic planning leading the acquisition divestiture and equity investing process as well as a major restructuring effort to realign the franchise in november  richard was named to the global management board of ortho clinical diagnostics as vp of new business development strategic assessment of the business in partnership with the global chairman resulted in the recommendation to jj senior management to divest the ocd business unit announced in june  to carlyle group for bn richard retired from jj dec  and in april of  joined west health a c  notforprofit as evp of business development chief strategy officer and a comanager of the west health investment fund richard held overall responsibility for the strategic portfolio process and led a major org redesign and restructuring in  resulting in a more streamlined and outcome oriented program selection and management process focused on senior care in alignment with major program goals of the gary and mary west foundation the benefactors of west health while at west health richard was also president of the center for medical interoperability a c notforprofit founded by the gary and mary west foundation aimed at bringing the purchasing power of the provider community to bear on developing an openarchitecture solution to the problem of lack of interoperability of regulated devices the board of cmi was announced in june of  at the completion of this work richard retired from west health michael rechtiene advisors michael rechtiene business advisor mike is a strategic growth leader that builds outstanding growth companies and leadership teams he has held global medical device leadership positions at johnson  johnson including worldwide president animas corporation and worldwide general manager therakos inc prior to therakos he held senior marketing and sales positions at the biotechnology company centocor and consumer packaged goods leader mcneil consumer and specialty pharmaceuticals mike’s stand for the development of global talent and the shifting of internal mental models has led to radical innovation and unprecedented business and employee engagement improvement results under his leadership mike’s broad academic interests and appointments have included his work as an advisor to the center for global leadership at the villanova school of business and to the sei center for entrepreneurship at the wharton school of the university of pennsylvania mike serves as an adjunct faculty member in marketing at the wharton school mike received his undergraduate degree at the villanova school of business and his mba from the wharton school contact wwwlinkedincominmichaelrechtiene connect with michael on linkedin bill mcclellan advisors bill mcclellan business advisor bill mcclellan is an experienced finance executive and cfo most recently for onx life technologies inc a heart surgery medical device company which sold to cryolife in  mr mcclellan currently serves on the board of apollo endosurgery and chairman of their audit committee  he also serves on various advisory and nonprofit boards early in his career he spent nine years specializing in healthcare with the public accounting firm pricewaterhousecoopers formerly price waterhouse followed by executive management positions with phycor inc physicians trust inc us orthopedics inc and acxiom corporation bill is a graduate of abilene christian university and a certified public accountant contact httpswwwlinkedincominbillmcclellan connect with bill on linkedin sandra thompson advisors sandra thompson business advisor sandra is a business transformation and innovation expert working on and with executive teams across healthcare services technology and consumer products industries  her experience running internal venture businesses multiple functional areas and postacquisition integrations have consistently lead to breakthrough innovations and business and cultural turnarounds  during her tenure at johnson  johnson sandra lead new business ventures for medical device sector in emerging markets the postacquisition integration of animas corporation into johnson  johnson and strategy and human resources functions at the management board level  prior to jj sandra lead the global marketing transformation efforts at unisys corporation  human resources and it transformation at caremark rx and built an industry leading integrated technology services business  sandra brings a unique blend of human systems expertise grounded in extensive business leadership success sandra’s results in leadership and culture turnarounds have been recognized as best practices in training  development magazine sandra’s undergraduate education is in psychology and marketing and graduate education in organizational development and leadership she holds master’s certifications in leadership assessments executive coaching and strategic planning sandra has been a guest lecturer on transformational leadership at leading institutes and wharton fellows program eric roth advisors eric roth business advisor eric roth is currently a shareholder at stearns weaver miller a florida based law firm eric previously served as assistant general counsel for johnson  johnson and vice president law for cordis corporation  eric regularly counsels clients in the life sciences sector and medical device companies in particular  he has worked extensively with clients on the development and implementation of healthcare compliance policies and programs and provides clients with training and counseling on topics such as the anti kickback statute and proper documentation of company interactions with healthcare providers eric has extensive experience in negotiating and documenting clinical trial agreements as well as commercial transactions such as supply licensing distribution and strategic alliance agreements with external suppliers original equipment manufacturers and strategic partners he also provides counsel to company management in the areas of corporate compliance litigation strategy general commercial matters pricing and contracting strategies and product liability issues additionally eric counsels clients on a variety of employment law issues including enforcement of noncompetition and nonsolicitation agreements severance and separation agreements compliance with corporate progressive discipline policies and discrimination and retaliation claims eric earned his ba from the university of pennsylvania and his jd from the georgetown university law center contact wwwlinkedincompubericsrothbb connect with eric on linkedin dennis donohoe md advisors dennis donohoe md business advisor currently dr donohoe manages a clinical and regulatory consulting service that reviews medical and surgical devices as well as devicedrug combination products  prior to this he had a long tenure as johnson  johnson’s worldwide vice president heading up various clinical regulatory cardiology endovascular and neurovascular divisions among his other accomplishments he has over  years of medical experience in various private and public settings  dr donohoe earned his ba with honors from lasalle university and his md from the milton s hersheymedical center at penn state university  contact wwwlinkedincompubdennisdonohoeba connect with dennis on linkedin robert oholla advisors robert oholla business advisor bob was formerly the worldwide vice president of regulatory affairs at johnson  johnson bob is a health products executive that has over thirty years experience including research and development quality and compliance regulatory affairs policy development and product sterilization bob has also written several publications regarding health products bob received his ba from upsala college his aa from union college and his mba from fairleigh dickinson university contact wwwlinkedincompubrobertoholla connect with robert on linkedin marlene wright barton advisors marlene wright barton business advisor marlene wright barton is cofounder of barton  blank a regulatory consulting firm focused on medical devices founded in early  with tony blank previously marlene served as president of wright regulatory consulting llc in fort lauderdale florida where she assists medical device companies in developing and executing regulatory strategies  she has extensive experience in regulatory affairs for class ii and class iii medical devices and has been responsible for worldwide regulatory approvals for cardiovascular class ii  iii combination productions  among some of her significant investigational device exemption ide product approvals are the cypher® the first drugeluting stent approval for japan and checkmate the first brachytherapy system approval for the united states additional ide approvals include products for neurovascular use in the united states  which led to premarket approval   marlene received her bs from the state university of new york and graduate studies in business from empire state college in new york  contact wwwlinkedincompubmarlenebartona connect with marlene on linkedin dan walsh advisors dan walsh scientific advisor with more than  years of seniorlevel leadership experience overseeing business product and technology development for therakos jj pfizer phillips baxter and others dan is an innovation leader of cuttingedge advancements and goalsurpassing results an expert in delivering groundbreaking medical device products to market as well as organicacquisitive growth strategies dan offers proven success in… ► leading all phases of product development from rd commercial scaleup and regulatory approvals to manufacturing and market launch for dozens of careenhancing and lifesaving medical devices services and therapies ► delivering  topselling medical devices  systems to market including ✫ fetal neurological  portable patient monitors ✫ deep brain drug delivery systems ✫ minimally invasive surgical instruments ✫ advanced endoscopy  wound care solutions ✫ coronary stents  replacement valves ✫ photopheresis therapy that harnesses the healing power of the patient’s own immune system ► accelerating rd timelines streamlining scaleup and strengthening qacompliance while lowering costs and manufacturing risks dan excels in resolving issues that inevitably arise throughout the rd commercialization and approvals process which has led to one of his consulting practice specialties as a “medtech midwife” due to my strengths in guiding all phases of the product “birthing” process ► managing and mentoring team members to achieve beyond their own expectations contact wwwlinkedincomindanielfwalshjr connect with dan on linkedin httpstwittercomdanielfwalshjr follow dan on twitter tony blank advisors tony blank business advisor tony blank cofounder of barton  blank a regulatory consulting firm focused on medical devices previously spent the past  years at boston scientific in both corporate and business regulatory leadership roles  while at boston he led their crv regulatory teams in obtaining numerous regulatory approvals for class ii  iii medical devices and combination products tony also represented the medical device industry and regulatory professionals on numerous policy issues through work with advamed working groups including pediatric devices advertising and promotion and reprocessing  tony is involved in developing and delivering meaningful educational programs in the field of regulatory affairs including cofacilitating the recent inaugural global regulatory strategy summit sponsored by medical device summit  he will continue to actively participate as a faculty member for the advamed ide and pma submissions workshops  in addition to his time at boston scientific tony has worked within the cardiopulmonary surgical ophthalmic vascular access and critical care industries tony recieved his bs from colorado state in chemical engineering with additional graduate studies from the university of california berkley contact wwwlinkedincompubtonyblankb connect with tony on linkedin ben avancena advisors ben avancena business advisor benjamin ben avancena has been deeply involved with the healthcare domain through his work over the past  years  currently he serves as ceo and senior partner of oneasia healthcare solutions a healthcare consulting firm focused on helping companies gain access to the asia market  prior to this ben spent time with johnson  johnson where he was international vicepresident north asia member of the johnson  johnson medical asia pacific regional leadership team chairman of the lifescan diabetes care franchise and chairman johnson  johnson asia pacific contributions committee  throughout his career working with many globally focused companies ben has acquired a deep appreciation of diverse cultures enabling him to easily embrace people and organizations internationally he has led from the front in all his leadership positions turning around businesses building strong organizations with enviable leadership pipelines developing innovative strategies to enter new markets and consistently delivering strong business growth  additionally ben cochaired the strategic partnership program between johnson  johnson the chinese ministry of health and the chinese state food  drug administration and was a member of the board of junior achievement china a nonprofit organization dedicated to developing and inspiring the youth  ben earned his bs from lewis  clark college and a ms in international management from the thunderbird school of global management contact phlinkedincompubbenjaminavancenaaba connect with ben on linkedin phil deschamps advisors phil deschamps business advisor phil offers extensive experience in pharmaceutical and healthcare commercialization the depth of his expertise stems from his   years in the health sciences  industry half of which was spent at bristol myers squibb and half on the service side as ceo of gsw worldwide a leading healthcare commercialization company at gsw deschamps was president and ceo and was responsible for the gsw worldwide operations which includes offices in the  major markets around the world with a turnover of m   he primarily consulted on global marketing and commercialization new business model development for pharmaceutical device and diagnostics companies before joining gsw worldwide  deschamps served as director of neuroscience marketing at bristol myers squibb bms in princeton nj where he participated on several prelaunch global marketing teams in the neuroscience and pain therapeutic areas  he also held several marketing positions in the neuroscience pain and metabolic therapeutic areas throughout his career phil received a bs in chemistry from the university of ottawa canada contact wwwlinkedincompubphildeschampsa connect with phil on linkedin victor chance advisors victor chance business advisor victor vic chance is a healthcare executive with nearly  years of operations management experience he recently retired from his role as vice president external operations and supply chain chief procurement officer cpo for the mdd global supply chain organization of johnson  johnson in this role vic was responsible for the external supplier network along with all associated performance improvement initiatives through his leadership the procurement organization applied a consistent focus to quality service and productivity across the mdd external supply network vic also played a leadership role in ensuring that the procurement organization developed leaders with the broad experiences in manufacturing new product development and supply chain management required to ensure future organizational success prior to this role vic was the worldwide vice president of operations for mdd’s cordis franchise where he was responsible for directing the company’s global manufacturing supply chain management and strategic sourcing functions the cordis operations organization was noted for the introduction of the breakthrough cypher drugeluting stent and was recognized for operations excellence by receiving the shingo prize for manufacturing as well as being a two time winner of industry week’s “america’s best plants” award prior to joining cordis vic was vice president of worldwide operations for mdd’s orthoclinical diagnostics franchise where he deployed an operational reengineering program using johnson  johnson process excellence processes the changes implemented resulted in significant improvements in productivity quality response and customer satisfaction vic joined johnson  johnson in  after  years at the alliedsignal corporation where he was a key contributor to the company’s operational excellence transformation at alliedsignal he was heavily involved in the deployment of six sigma and lean manufacturing during the course of multiple operations management assignments in several businesses vic is wellknown for his accomplishments in implementing lean production systems and six sigma programs with a strong track record of generating annual productivity quality and service improvements vic earned a bs from auburn university and an ms in manufacturing engineering from the university of bridgeport connecticut contact httpswwwlinkedincompubvictorchancebbab connect with victor on linkedin william e cohn md advisors william e cohn md scientific advisor dr william cohn has been awarded over twenty patents for his medical devices which help surgeons operate on a beating heart a task thought to be impossible for many years a native houstonian he graduated from baylor college of medicine in  and was recruited to boston’s bethisrael hospital where he focused on minimally invasive surgery dr cohn creates procedures and devices to minimize the invasiveness of heart surgery and uses new techniques that avoid the employment of the heartlung machine thereby allowing the heart to continue beating during surgery and reducing the risk to the patient in spring of  dr cohn returned to houston to join the renowned texas heart institute at st luke’s episcopal hospital as well as the faculty at baylor college of medicine today he continues his clinical research activity at the texas heart institute and st luke’s episcopal hospital where he is serving as director of minimally invasive surgical technology and codirector of the cardiovascular research laboratories contact wwwlinkedincompubwilliamcohnab connect with william on linkedin ben g streetman phd advisors ben g streetman phd scientific advisor dr ben streetman earned his phd in electrical engineering from the university of texas at austin in  he joined the faculty of the university in  he was the founding director of the microelectronics research center dr streetman is a member of the american academy of arts and sciences as well as the national academy of engineering the nation’s highest honor for engineering professionals he is a fellow of both the institute of electrical and electronics engineers and the electrochemical society he was awarded the education medal of the institute of electrical and electronics engineers ieee the world’s largest professional engineering society with more than  members worldwide dr streetman became dean of the college of engineering in  his teaching and research interests involve semiconductor materials and devices he is the author of the book solid state electronic devices which has been translated into japanese korean chinese and polish he has published more than  articles in the technical literature thirtyfour students of electrical engineering materials science and physics have earned their phd’s under his direction weikan chu phd advisors weikan chu phd scientific advisor dr chu currently is a robert a welch professor in physics and a distinguished university professor at the university of houston his professional experience includes deputy director of research  at the texas center for superconductivity a research professor of physics at the university of north carolina  a staff advisory and then senior engineer at ibm  and a research fellow and senior research fellow at caltech  he is the author of the book backscattering spectrometry and the editor of four books dr chu has authored or coauthored over  journal publications over  invited talks and conference presentations and  uspatents to date his research interest is related to ion beam characterization of materials and ion beam modification of materials such as ion implantation in semiconductors he is also an expert on high temperature superconductors hts in the area of hts thin film studies htsmagnetic bearing and levitation flywheels contact wwwlinkedincompubweikanchubb connect with wei on linkedin dimitris c lagoudas phd advisors dimitris c lagoudas phd scientific advisor dr dimitris lagoudas is the john and bea slattery chair of aerospace engineering director for the texas institute for intelligent bionano materials and structures for aerospace vehicles tiims at texas am university college station texas he is currently serving as director for the newly established texas institute for intelligent bionano materials and structures for aerospace vehicles chair of the executive committee of the faculty of materials science and engineering and as an associate vice president for research his research involves the design of multifunctional systems at nano micro meso and macro levels with appropriate methods developed to bridge the various length scales this research will develop multifunctional hierarchical structural materials systems that will carry structural loads store electrical energy assist in thermal management and protect against low and high velocity impact additionally multifunctional porous shape memory alloys at the micro scale will be developed and then integrated into smart structures relevant to multifunctional lightweight space applications steven l mcknight phd advisors steven l mcknight phd scientific advisor dr steven mcknight is a professor and distinguished chair in basic biomedical research and chairman of the department of biochemistry at the university of texas southwestern medical center at dallas he is also the cofounder of tularik inc acquired by amgen inc and cumbre inc he is known for his discovery of leucine zipper proteins dr mcknight was formerly an investigator at the howard hughes medical institute he is a member of the national academy of science and the american academy of arts and sciences dr mcknight is a recipient of many awards including his most recent induction into the hall of honor at the university of texas at austin college of natural sciences in  and he was awarded the monsanto award by the national academy of science dr mcknight directs an active research laboratory and has guided the department of biochemistry to substantial growth in the disciplines of chemistry biochemistry and biophysics dr mcknight is a member of the national academy of sciences the institute of medicine and the american academy of arts and sciences stephen g slade md advisors stephen g slade md scientific advisor dr stephen slade a specialist in presbyopia correction cataract surgery lasik implantable contact lenses and refractive surgery is a houston native whose private practice is in houston texas he attended tulane university and the university of texas medical school with a final elective year spent at guy’s hospital london graduating summa cum laude with highest honors he completed a residency at the lsu eye center in new orleans and fellowships in corneal surgery at baylor college of medicine in houston and in new york new york on project orbis dr slade is a fellow of the american academy of ophthalmology and the american college of surgeons he is an active teacher of surgical techniques and has taught lectured to and certified over  surgeons on lasik and lamellar refractive surgery in  along with stephen brint md he performed the first lasik in the united states later he performed the first custom lasik ablation based on topography in the united states he has since done tens of thousands of cases he has received numerous awards and has produced many articles book chapters holds four patents or patents pending in the field and has authored five textbooks on refractive surgery he has been featured in numerous news segments aired on cbs abc and pbs and was the featured surgeon on the emmy award winning pbs documentary “ by ” narrated by walter cronkite pitch us  ptv healthcare capital how will you enable healthcare innovation my name is im currently seeking to raise  for my company in the sector connected healthhealthcare ithealthcare servicesmedical devicesdiagnosticstherapeutic drugs drug discovery here is my elevator pitch in  words or less you can find additional details in the attached materials please note file size must be less than mb i can be contacted at news spotlight jul  apollo endosurgery inc announces closing of public offering and underwriters’ full exercise of overallotment option more » jul  apollo endosurgery inc announces pricing of  million public offering more » jun  new podcast ptv senior regulatory advisor tony blank on the consumerization of the fda more » jun  watch apollo endosurgery featured on today  nbc nightly news more » may  listen eye on the prize – a conversation with lasik pioneer dr stephen slade more » may  watch ptv’s featured session at sxsw more » may  apollo endosurgery features industryleading endoscopic procedure portfolio at digestive disease week®  conference ddw more » apr  asuragen strengthens repetitive sequence and short structural variant intellectual property portfolio more » apr  ortho kinematics raises  million series d equity financing more » apr  ptv’s lauren chauret named austin under  award winner more » glycomimetics  ptv healthcare capital glycomimetics innovation today hope for healing tomorrow headquartered in gaithersburg maryland glycomimetics is a publicly traded clinicalstage biotechnology company that utilizes novel and proprietary glycobiology technology to develop treatments for diseases especially those with high unmet needs the company’s mission is to continue to advance its pipeline providing hope for patients with sickle cell cancer and other serious diseases wwwglycomimeticscom glyc stock activity rivipansel gmi in october  glycomimetic entered into an exclusive worldwide licensing agreement with pfizer inc to develop glycomimetic’s lead drug candidate rivipansel a treatment for vasoocclusive crisis voc associated with sickle cell disease the potential value of the agreement for glycomimetics is approximately  million including an upfront payment as well as developmental regulatory and commercial milestones connect withglycomimetics bioform medical  ptv healthcare capital bioform medical intelligent solutions for aesthetics headquartered in san mateo california bioform medical inc was a medial aesthetics company that developed products that enhance aesthetic procedures performed in dermatology and plastic surgery practices bioform’s lead product  radiesse® is alonglasting dermal filler for use in facial aesthetics wwwradiessecom “with bioform medical we expand our product offering in the highgrowth aesthetic market and increase our direct commercial presence in the united states and europe this transaction strengthens our operating foundation and builds on merz’s history of providing innovative and effective products to the aesthetic medical community and the patients we serve” dr martin zugel chairman of the merz management board connect  ptv healthcare capital we act with integrity in all that we do we believe people are our most valuable asset we are committed to constantly challenging our assumptions methods and knowledge to ensure we are worldclass investors partners and leaders in the future of healthcare contact us headquarters  n capital of texas hwy suite b austin texas  p  email business plans bplansptvhccom investors laurenptvhccom media alexaptvhccom social media   directions our offices are located in the san clemente office complex located at the southwest corner of  and westlake drive from  n turn right at westlake drive turn left into the san clemente office building followed by an immediate right for building b enter the lobby and walk past the elevator bank ptv’s offices are the large glass doors on the right tweets by ptvhc ptv sciences ii l p  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address  n capital of texas hwy suite b austin tx   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg pretpwins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  apenapollo endosurgery incdehealthbioprdbiological products no diagptv sciences ii l ptxtpd  ldrhldr holding corpdehealthmdeqsurgical  medical instrumentptv sciences ii l ptxtpdd dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved ptv sciences ii l p top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active ptv sciences ii l p • austin tx how do i update this listing ptv sciences ii l p is based out of austin whalewisdom has at least  dg filings in our database for ptv sciences ii l p summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from ptv sciences ii l p enter your email address below and choose submit your email cancel contact info ptv sciences ii l p  n capital of texas hwy austin tx     business phone    sec sic codebiological products no disgnostic substances recent sec filings  filed on  sc d filed on   filed on   filed on  sc ga filed on  sc g filed on   filed on  sc ga filed on   filed on   filed on  current dg holdings stock sector shares held market value rank source source date apollo endosurgery inc apen health care    d  ziopharm oncology inc ziop health care    g  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free insider trading  ptv sciences ii l p  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  ptv sciences ii l p select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing other  am nana lpath inc apen ptv sciences ii l pptv iv lpptv special opportunities i lpanderson rick dcrawford matthew s owner   direct view other  am nana lpath inc apen ptv sciences ii l pptv iv lpptv special opportunities i lpanderson rick dcrawford matthew s owner   direct view other  am nana lpath inc apen ptv sciences ii l pptv iv lpptv special opportunities i lpanderson rick dcrawford matthew s owner   direct view   secformcom all rights reserved archives        thu  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  ptv sciences ii l p  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors ptv sciences ii l p check out list of companies and businesses related to ptv sciences ii l p find out ptv sciences ii l p address and contact details view other people related to ptv sciences ii l p  coworkers colleagues companions etc address  n capital of texas hwy suite b austin  tx companies related to ptv sciences ii l p cikcompany namepositioncompany addressintersect ent inc owner  adams drive menlo park  ptv sciences ii l p on the web persons related to ptv sciences ii l p  intersect ent incnamepositioncityrick d andersondirector austinrick d andersondirector austinrick d anderson owner austinrobert h binney jrvice president sales menlo parkrobert h binney jrvice president sales menlo parkgwen r carscaddenchief people officer menlo parktansey caseymenlo parkde clercq casperpalo altomatthew s crawfordaustinmatthew s crawfordaustinjeffrey crowepalo altomead jr danamenlo parkclercq casper l dedirector palo altolisa earnhardtpresident and ceo extonlisa d earnhardtsee remarks menlo parklisa d earnhardtpresident and ceo menlo parkmelrose evanaustinirwin federmanmenlo parkmark j fletcherdirector minneapolismark j fletcherminneapolismoll fredericpalo altomoll fredericmenlo parkkieran gallahuedirector poway capromod haquepalo altojeryl l hillemanchief financial officer santa clarajeryl l hillemanchief financial officer menlo parkmatthew d howardpalo altorichard e kaufmansr vp chief operating officer menlo parkrichard e kaufmansvp  chief operating officer menlo parkkleiner perkins caufield  byers xia lp owner menlo parkkleiner perkins caufield  byers xi b lpmenlo parkkpcb xi associates llcmenlo parksteven m krauszsunnyvalesteven m krauszmenlo parkdavid aaron lehmangeneral counsel pleasantondavid e liddlemenlo parkdavid e liddlemenlo parkearnhardt lisapalo altoearnhardt lisamenlo parkcynthia l lucchese pleasantoncynthia l lucchesedirector menlo parkfletcher markminneapolispaul a matteuccimenlo parkchas mckhannchief commercial officer menlo parkdana g mead jrdirector indianapolisdana g jr meaddirector menlo parkdana g jr meaddirector menlo parkfrederic h molldirector mountain viewfrederic h molldirector menlo parkde martini monikapalo altode martini monikamenlo parknorwest venture partners xi lp owner palo altonorwest venture partners xii lppalo altopinto technology ventures gp ii lpaustinpinto technology ventures gp ii lpaustinpinto tv gp co llcaustinpinto tv gp co llcaustinpresidio management group ix llc owner menlo parkkaufman richardpalo altokaufman richardmenlo parkanderson rickaustinjonathan d rootmenlo parkjames stambaughvp clinical affairs menlo parkjames stambaughvp clinical and reimbursement menlo parkjames stambaughvp clinical affairs  reimb menlo parksusan p stimsonmenlo parksusan p stimsonvice president marketing menlo parkcasey m tanseydirector menlo parku s venture partners ix l pmenlo parkw anthony vernondirector san franciscoamy wolbeckvp regulatory affairs  qlty menlo parkamy wolbeckvp reg affairs and quality menlo parkphilip m youngmenlo park potentially same personnamecitycountryptv sciences ii l paustintxptv sciences ii l paustinca   ptv sciences ii lp private company information  bloomberg july    pm et capital markets company overview of ptv sciences ii lp snapshot people company overview ptv sciences ii lp specializes in seed early mid and late stages and growth investments it prefers to invest in the life sciences medical devices and material science sector the fund seeks to make investments in and around lone star state it invests between  million and  million in a company  north capital of texas highwaysuite baustin tx united statesfounded in  phone  fax  key executives for ptv sciences ii lp mr matthew s crawford founding managing director age  compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact ptv sciences ii lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version jeffery j sheldon and andras konya md phd appellants v pinto technology ventures lp pinto tv annex fund lp ptv sciences ii lp rivervest venture fund i lp rivervest venture fund ii lp rivervest venture ii ohio lp bay city capital fund iv lp bay city capital fund iv coinvestment fund lp chris owens bill burke reese terry and craig walker appellees  texas lawyer jeffery j sheldon and andras konya md phd appellants v pinto technology ventures lp pinto tv annex fund lp ptv sciences ii lp rivervest venture fund i lp rivervest venture fund ii lp rivervest venture ii ohio lp bay city capital fund iv lp bay city capital fund iv coinvestment fund lp chris owens bill burke reese terry and craig walker appellees october   share share on linkedin facebook share on twitter share on google share with email send thank you for sharing your article was successfully shared with the contacts you provided reprints court of appeals of texas fourteenth district houston cv kem thompson frost the trial court dismissed shareholder claims based on a delaware forumselection clause the shareholders claims all arise out of alleged noncontractual general obligations imposed by law rather than out of the shareholders agreement if under applicable law the claims a plaintiff asserts are not within the scope of a forumselection clause the existence of unasserted claims that are within the scope of this clause does not cause the asserted claims to fall within the scope of the clause the trial court’s dismissal is reversed and remanded sheldon v pinto technology ventures lp houston’s th court of appeals no cv  this premium content is reserved for texas lawyer subscribers continue reading by getting started with a subscription subscribe now for unlimited access already a subscriber log in now more from texas lawyer do law firms enable alcoholism i fell for a phishing email and the law couldnt help me transgender attorney finds strong support from her firm law school association ditches texas over immigration bathroom bill more from the alm network previous next ubers greyball program puts new focus on legal dept the recorder  companies back transgender teen in scotus fight the national law journal after yahoo are inhouse counsel jobs at risk over cybersecurity corporate counsel covington pays to end m conflicts row the am law daily as law prof gorsuch banned laptops garnered respect the national law journal behind the m curtain how skadden handed wilkinson her first trial loss the litigation daily davis polk partner says biorad gc kept pushing flimsy claims the recorder exxon insists its free speech case against attorneys general be heard in texas court texas lawyer beyonce tebow for prez invalid votes spiked in florida daily business review three things to know about neil gorsuch scotus frontrunner the national law journal new goodwin procter partner a transgender trailblazer in big law the am law daily outside counsel complained about biorad gc ceo says the recorder lawyers spar over rex tillerson depo in climate change suit the recorder i beg you to recuse me anna nicole smith judge finally gets his wish texas lawyer lawyer gets green light to sue gawker over rape comments the national law journal law school classmates call priebus a voice of reason for trump white house cybersecurity madness  things that really matter and  that dont corporate counsel new florida house speaker wants crackdown on lobbyists daily business review pence and his big law counsel wage their own email secrecy fight the litigation daily fdas expanded zikatesting guidance will test blood centers the national law journal